In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms

Journal of Medical Microbiology

Volumn 60, Issue 11, 2011, Pages 1708-1710

  Ku, Tsun Sheng N ^a,b   Bernardo, Stella M ^a,b   Lee, Samuel A ^a,b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; BIOFILM; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; FUNGAL METABOLISM; FUNGAL STRAIN; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA TROPICALIS; CANDIDIASIS; ECHINOCANDINS; HUMANS;

EID: 80054729058     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.032235-0     Document Type: Letter

References (22)

1. Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R. & López-Ribot, J. L. (2002). In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46, 3591-3596.
2. Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B. & Viscoli, C. (2006). Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6, 21.
3. Bizerra, F. C., Melo, A. S., Katchburian, E., Freymuller, E., Straus, A. H., Takahashi, H. K. & Colombo, A. L. (2011). Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species. Antimicrob Agents Chemother 55, 302-310.
4. Chamilos, G., Lewis, R. E., Albert, N. & Kontoyiannis, D. P. (2007). Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob Agents Chemother 51, 2257-2259.
5. Choi, H. W., Shin, J. H., Jung, S. I., Park, K. H., Cho, D., Kee, S. J., Shin, M. G., Suh, S. P. & Ryang, D. W. (2007). Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob Agents Chemother 51, 1520-1523.
6. Cocuaud, C., Rodier, M. H., Daniault, G. & Imbert, C. (2005). Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56, 507-512.
7. Ferreira, J. A., Carr, J. H., Starling, C. E., de Resende, M. A. & Donlan, R. M. (2009). Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob Agents Chemother 53, 4377-4384.
8. Fleischhacker, M., Radecke, C., Schulz, B. & Ruhnke, M. (2008). Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. Eur J Clin Microbiol Infect Dis 27, 127-131.
9. Garcia-Effron, G., Park, S. & Perlin, D. S. (2009). Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53, 112-122.
10. Jacobson, M. J., Piper, K. E., Nguyen, G., Steckelberg, J. M. & Patel, R. (2008). In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob Agents Chemother 52, 2242-2243.
11. Jacobson, M. J., Steckelberg, K. E., Piper, K. E., Steckelberg, J. M. & Patel, R. (2009). In vitro activity of micafungin against planktonic and sessile Candida albicans isolates. Antimicrob Agents Chemother 53, 2638-2639.
12. Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. (2002). Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46, 1773-1780.
13. Melo, A. S., Colombo, A. L. & Arthington-Skaggs, B. A. (2007). Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 51, 3081-3088.
14. Miceli, M. H., Bernardo, S. M. & Lee, S. A. (2009a). In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 34, 326-332.
15. Miceli, M. H., Bernardo, S. M. & Lee, S. A. (2009b). In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms. Int J Antimicrob Agents 34, 500-502.
16. Nucci, M., Queiroz-Telles, F., Tobón, A. M., Restrepo, A. & Colombo, A. L. (2010). Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 51, 561-570.
17. Odabasi, Z., Paetznick, V., Rex, J. H. & Ostrosky-Zeichner, L. (2007). Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother 51, 4214-4216.
18. Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2008). In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46, 150-156.
19. Ramage, G. & López-Ribot, J. L. (2005). Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med 118, 71-79.
20. Stevens, D. A., Espiritu, M. & Parmar, R. (2004). Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48, 3407-3411.
21. Tan, T. Y., Tan, A. L., Tee, N. W., Ng, L. S. & Chee, C. W. (2010). The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Mycoses 53, 515-521.
22. Wiederhold, N. P., Grabinski, J. L., Garcia Effron, G., Perlin, D. S. & Lee, S. A. (2008). Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrob Agents Chemother 52, 4145-4148.